IMA Advisory Services’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73K Buy
63
+21
+50% +$558 ﹤0.01% 1128
2026
Q1
$1.13K Buy
42
+1
+2% +$30 ﹤0.01% 758
2025
Q4
$1.26K Buy
+41
New +$1.28K ﹤0.01% 746

Other funds holding GMAB

IMA Advisory Services's GMAB Position: Q2 2026 in Review

IMA Advisory Services increased its Genmab (GMAB) stake by 50% in Q2 2026, buying an estimated $558 and bringing the position to 63 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

IMA Advisory Services first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • IMA Advisory Services held 63 shares of Genmab worth $1.73K as of Q2 2026.
  • IMA Advisory Services bought 21 Genmab shares in Q2 2026, an estimated $558.
  • Genmab made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1128 holding.
  • IMA Advisory Services first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.